Business Description
AstraZeneca PLC
ISIN : BRA1ZNBDR003
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.16 | |||||
Equity-to-Asset | 0.39 | |||||
Debt-to-Equity | 0.78 | |||||
Debt-to-EBITDA | 2.06 | |||||
Interest Coverage | 6.27 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.81 | |||||
Beneish M-Score | -2.69 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 15.4 | |||||
3-Year EBITDA Growth Rate | 14 | |||||
3-Year EPS without NRI Growth Rate | 37.2 | |||||
3-Year FCF Growth Rate | 38.8 | |||||
3-Year Book Growth Rate | 31.1 | |||||
Future 3-5Y EPS without NRI Growth Rate | 34.77 | |||||
Future 3-5Y Total Revenue Growth Rate | 9.62 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 65.65 | |||||
9-Day RSI | 60.04 | |||||
14-Day RSI | 56.33 | |||||
6-1 Month Momentum % | -11.38 | |||||
12-1 Month Momentum % | 17.73 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.93 | |||||
Quick Ratio | 0.71 | |||||
Cash Ratio | 0.19 | |||||
Days Inventory | 206.09 | |||||
Days Sales Outstanding | 77.11 | |||||
Days Payable | 643.9 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.83 | |||||
Dividend Payout Ratio | 0.59 | |||||
3-Year Dividend Growth Rate | 2.9 | |||||
Forward Dividend Yield % | 1.83 | |||||
5-Year Yield-on-Cost % | 1.95 | |||||
3-Year Average Share Buyback Ratio | -5.7 | |||||
Shareholder Yield % | 1.77 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 80.92 | |||||
Operating Margin % | 21.07 | |||||
Net Margin % | 12.7 | |||||
FCF Margin % | 13.36 | |||||
ROE % | 16.64 | |||||
ROA % | 6.35 | |||||
ROIC % | 10.15 | |||||
ROC (Joel Greenblatt) % | 90.14 | |||||
ROCE % | 13.08 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 32.84 | |||||
Forward PE Ratio | 15.36 | |||||
PE Ratio without NRI | 27.59 | |||||
Shiller PE Ratio | 51.38 | |||||
Price-to-Owner-Earnings | 23.56 | |||||
PEG Ratio | 4.31 | |||||
PS Ratio | 4.19 | |||||
PB Ratio | 5.38 | |||||
Price-to-Free-Cash-Flow | 31.78 | |||||
Price-to-Operating-Cash-Flow | 18.94 | |||||
EV-to-EBIT | 24.88 | |||||
EV-to-Forward-EBIT | 15.4 | |||||
EV-to-EBITDA | 16.16 | |||||
EV-to-Forward-EBITDA | 11.69 | |||||
EV-to-Revenue | 4.69 | |||||
EV-to-Forward-Revenue | 4.11 | |||||
EV-to-FCF | 34.24 | |||||
Price-to-Projected-FCF | 2.45 | |||||
Price-to-DCF (Earnings Based) | 1.03 | |||||
Price-to-DCF (FCF Based) | 2.65 | |||||
Price-to-Median-PS-Value | 0.92 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.37 | |||||
Earnings Yield (Greenblatt) % | 4.02 | |||||
FCF Yield % | 3.18 | |||||
Forward Rate of Return (Yacktman) % | 14.24 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
AstraZeneca PLC Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil R$) | 266,859.698 | ||
EPS (TTM) (R$) | 1.811 | ||
Beta | -0.26 | ||
Volatility % | 25.06 | ||
14-Day RSI | 56.33 | ||
14-Day ATR (R$) | 1.618231 | ||
20-Day SMA (R$) | 67.447 | ||
12-1 Month Momentum % | 17.73 | ||
52-Week Range (R$) | 50.8 - 82.8 | ||
Shares Outstanding (Mil) | 18,603.81 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
AstraZeneca PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
AstraZeneca PLC Stock Events
Event | Date | Price(R$) | ||
---|---|---|---|---|
No Event Data |
AstraZeneca PLC Frequently Asked Questions
What is AstraZeneca PLC(BSP:A1ZN34)'s stock price today?
When is next earnings date of AstraZeneca PLC(BSP:A1ZN34)?
Does AstraZeneca PLC(BSP:A1ZN34) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |